Sophia Antipolis, France – 30 Aug 2020: Premenopausal women have good long-term outcomes after a heart attack, according to late breaking research presented today at ESC Congress 2020.1
“Previous research has shown that women are more likely to die after a heart attack than men,” said principal investigator Professor Diego Ardissino of Parma University Hospital, Italy.2 “Our study shows that this does not hold true before the menopause, when women are still exposed to oestrogen, a hormone that protects against heart disease.”
The Italian Genetic Study on Early-onset Myocardial Infarction compared outcomes of women and men under 45 who had a heart attack. The study included 2,000 patients (1,778 men and 222 women) who presented to hospital with a heart attack before the age of 45 at 125 Italian coronary care units between 1998 and 2002. The primary endpoint was a composite of recurrent heart attack, stroke, or death from cardiovascular disease.
During a median follow-up of 20 years, the primary composite endpoint occurred in 25.7% of women compared to 37.0% of men (hazard ratio [HR] 0.69; 95% confidence interval [CI] 0.52-0.91? p=0.01).
When the components of the primary endpoint were analysed separately, the researchers found that second heart attacks were less frequent in women compared to men (14.2% vs. 25.4%? HR 0.53; 95% CI 0.37-0.77? p
Smoking (46.5% vs. 42.8%), alcohol consumption (65.3% vs. 27.4%), high blood lipids (62.3% vs. 50.7%) and diabetes (7.8% vs. 5.4%) were more frequent in men compared to women (all p
Professor Ardissino said the better prognosis in premenopausal women compared to men was likely related to different mechanisms behind the heart attacks. Women were more than twice as likely to have healthy arteries than men (36.5% vs. 15.4%; p
He said: “In men, coronary events were mostly due to blocked arteries, while in women they had other causes such as coronary dissection which is known to have a more favourable prognosis and a lower risk of recurrence.”
At discharge from hospital, men were more likely than women to be prescribed medications to protect against second heart attacks, including beta-blockers, aspirin, and angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). The likelihood of statin treatment was similar in men and women.
Professor Ardissino said: “The disparity in prescribing may be due to the lower burden of coronary artery disease found in women in the study. It could also relate to the general under-prescribing of medication for women compared to men seen in other studies of acute cardiac events.”
He concluded: “In contrast to the prevailing literature, women experiencing an early-onset heart attack have favourable long-term outcomes compared to men, despite being prescribed fewer preventive medications.”
Notes to editors
Authors: ESC Press Office
Mobile: +33 (0)7 85 31 20 36
The hashtag for ESC Congress 2020 is #ESCCongress.
Follow us on Twitter @ESCardioNews
This press release accompanies a presentation at ESC Congress 2020 – The Digital Experience.
It does not necessarily reflect the opinion of the European Society of Cardiology.
Funding: Atherosclerosis, thrombosis and vascular biology Italian Working Group; Regione Emilia-Romagna.
References and notes
1Abstract title: Sex-related differences in long-term outcomes after early-onset myocardial infarction.
2Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med. 1999;341:226-232.
About the European Society of Cardiology
The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.
About ESC Congress
ESC Congress is the world’s largest gathering of cardiovascular professionals contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2020 takes place online from 29 August to 1 September. More information is available from the ESC Press Office at email@example.com.
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.